Filing Details

Accession Number:
0000721371-16-000273
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-10 17:24:01
Reporting Period:
2016-08-08
Filing Date:
2016-08-10
Accepted Time:
2016-08-10 17:24:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
721371 Cardinal Health Inc CAH Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 310958666
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425512 S George Barrett 7000 Cardinal Place
Dublin OH 43017
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2016-08-08 20,428 $30.94 510,762 No 4 M Direct
Common Shares Disposition 2016-08-08 20,428 $83.75 490,334 No 4 S Direct
Common Shares Acquisiton 2016-08-09 129,818 $30.94 620,152 No 4 M Direct
Common Shares Disposition 2016-08-09 129,818 $83.76 490,334 No 4 S Direct
Common Shares Acquisiton 2016-08-10 99,754 $30.94 590,088 No 4 M Direct
Common Shares Disposition 2016-08-10 99,754 $83.44 490,334 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Common Shares Disposition 2016-08-08 20,428 $0.00 20,428 $30.94
Common Shares Common Shares Disposition 2016-08-09 129,818 $0.00 129,818 $30.94
Common Shares Common Shares Disposition 2016-08-10 99,754 $0.00 99,754 $30.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
665,561 2017-08-16 No 4 M Direct
535,743 2017-08-16 No 4 M Direct
435,989 2017-08-16 No 4 M Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.72 to $83.80, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 2 and 3 to this Form 4.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.59 to $84.00, inclusive.
  3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.24 to $83.80, inclusive.
  4. The option, representing a right to purchase a total of 685,989 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011.
  5. This stock option expires on August 16, 2017. On August 8, 2016, the reporting person adopted a Rule 10b5-1 trading plan to sell the remaining 435,989 shares subject to this option in the open market at prevailing market prices between November 2016 and February 2017, subject to minimum price thresholds specified in the plan. These transactions will be disclosed publicly in Form 144 and Form 4 Filings with the SEC. The goal of the transactions reported in this Form 4 and the subsequent transactions under the Rule 10b5-1 plan is to fully exercise the stock option in several transactions over a period of approximately six months.